Suven Life Sciences has received a product patent in Japan to be used for developing therapeutic agents which are useful in treating neuro-degenerative diseases.

Suven Life has said in a BSE filing that it has been granted “one process patent from Japan corresponding to the New Chemical Entities (NCEs) which are for the treatment of disorders associated with Neurodegenerative diseases.”

It added that the patents are valid till 2034.

Read EquityPandit’s Technical Analysis on Nifty Pharma